Mutants of Bacillus thuringiensis lacking either f3-exotoxin or y-endotoxin were compared for their virulence using pupae of a giant silk moth. Known doses of viable log-phase bacteria were injected, and the response was followed as the number of viable bacteria in the hemolymph. The results obtained imply that, in the system used, neither the f3-exotoxin nor the y-endotoxin and the sporeforming ability are of importance for virulence. Results with sterile culture filtrate from B. thuringiensis have given evidence for the production of two inhibitors, A and B, which interfere with the humoral defense system in pupae ofHyalophora cecropia. Inhibitor A, which blocked the lysis ofEscherichia coli, was precipitated by trichloroacetic acid and sensitive to heating. Inhibitor B, which blocked the killing of Bacillus cereus, was soluble in trichloroacetic acid and resistant to 90°C for 5 min. Both inhibitors are believed to contribute to the insecticidal nature of B. thuringiensis.
In microbial control of insect pests, Bacillus thuringiensis has so far been the organism most widely used (4, 5, 20) . Its insecticidal properties are generally believed to stem from two toxins with different specificities. The [3- exotoxin is a thermostable adenine nucleotide that is highly toxic for the larvae ofcertain flies (4, 20) . The y-endotoxin, which is both the main part of the crystalline inclusion and a normal constituent of the spore coat (7, 18, 21) , is highly toxic for larvae of many Lepidoptera (5, 20) . Besides these two rather well-characterized toxins, B. thuringiensis is also known to produce two hemolysins (14) and a metalloprotease (13) .
The virulence of.a bacterium, however, does not only depend on the production of toxins but also on the invasiveness of the strain and its ability to withstand the defense reactions of the host. The latter property can be due to passive resistance, as well as to the production of substances that block the immune system of the host. However, for vertebrates, only a limited number of microbial immune inhibitors are yet known (9, 11, 13, 15, 24) ; for invertebrate systems, lipid A seems to be the only such inhibiror reported (3, 8) .
We have previously shown that pupae of giant silk moths (family Saturniidae) have an inducible, multicomponent defense system that Present address: Department of Microbiology, University of Stockholm, Frescati, S-10405 Stockholm, Sweden. requires both ribonucleic acid (RNA) and protein synthesis to be expressed (2, 8) . We here report experiments which indicate that B. thuringiensis produces at least two substances that interfere with different parts of this immune system. To exclude as experimental factors the invasiveness of the toxins already known, we performed in vivo experiments with injected doses of mutants deficient in one or more toxins. We also report in vitro experiments with sterile culture filtrates and hemolymph from immunized pupae.
MATERIALS AND METHODS Bacterial strains, media, and growth conditions. We have used two parental strains ofB. thuringiensis. One of these, Bt7, is identical to strain HL2 of Somerville (19) , a crystal-negative mutant isolated from a streptomycin-and penicillin-resistant derivative of B. thuringiensis subsp. alesti. Strain Bt7 belongs to serotype 3, which does not produce any exotoxin (G. Carlberg, thesis, Univ. of Helsinki, Helsinki, Finland, 1973) . The other parental strain, Btll, is a streptomycin-resistant mutant (2), derived from an exotoxin-producing, crystal-negative line of B. thuringiensis subsp. gelechiae used by Sebesta et al. (16) . Our sporulation-deficient mutants, strains Bt72 and Btl2, were selected as rifampin resistant (23) and subsequently tested for heat sensitivity after growth in a sporulation medium (7) . Strain Bt74 is a spontaneous sporeforming revertant of strain Bt72.
Bacillus cereus is considered to be very closely related to B. thuringiensis (10, 21 
RESULTS
Virulence of different strains of B. thuringiensis. We first compared a set of different mutants for their ability to grow in untreated and immunized pupae of C. promethea. A dose of about 103 viable cells ofthe respective strains was injected into the thorax of the pupa. Three days later, aliquots of hemolymph were removed and assayed for the number of viable bacteria. Table 1 shows that an immunization can delay or prevent an infection with B. thuringiensis. The fact that strain differences were more obvious in immunized pupae indicates that the mutants could differ in their response to the immune system. In further experiments we have therefore only used immunized pupae.
To substantiate the strain differences seen in Table 1 , we performed dose-response curves with immunized pupae of C. promethea. The results in Fig. 1 show that the sporulationdeficient mutant Bt72 (spo-) was less virulent than its parental strain Bt7 (spo+). The revertant, strain Bt74, regained most of the virulence of strain Bt7. However, no difference was observed between strain Btll (spo+) and strain Btl2 (spo-). Thus, in this system sporulation as such does not always contribute to virulence (cf. references 6, 21). Figure 1 also shows that B. thuringiensis subsp. gelechiae (Btll and Btl2) was significantly less virulent than B. thuringiensis subsp. alesti (strain Bt7 and its derivatives).
One factor contributing to the virulence could be resistance to the immune system. To Figure 2 shows that strain Btll was more resistant to the antibacterial activity than strain Bt7. However, this difference is small compared with those recorded in Fig. 1 . It should also be emphasized that compared with the killing of E. coli or Bacillus subtilis (2, 3, 8) the killing of B. thuringiensis is a very slow and inefficient reaction. The curves in Fig. 2 also indicate that B. thuringiensis was killed by a multi-hit mechanism, contrary to the single-hit kinetics observed with E. coli (2) . In the controls with normal hemolymph, both strains grew slowly.
Some of our results in Table 1 indicate that during an infection B. thuringiensis could interfere with the defense system of the host. We therefore followed the antibacterial activity of two immunized pupae. Two days after vaccination, one ofthe pupae received an injection with B. thuringiensis, and the other was given an equal volume of sterile W-saline, a salt solution physiological to Lepidoptera (25) . Table 2 shows that the antibacterial activity was gradually suppressed simultaneously with the progression of the infection with B. thuringiensis. In the control, the antibacterial activity continued to rise. These results are consistent with the assumption that B. thuringiensis produces one INFECT. IMMUN. or more substances that either inhibit the antibacterial activity as such or interfere with the formation of one or more of the components needed for this activity.
Evidence for a production of two immune thuringiensis Bt7, and the other was given an equal volume of a physiological salt solution, W-saline (25) . Hemolymph samples were removed at the times indicated and assayed for their antibacterial activity (2) and for the number of viable cells of strain Bt7. munized pupae of H. cecropia. A sonicated extract of the same strain did not show much inhibitor effect. We therefore performed a series of experiments with sterile culture filtrate which aimed towards a preliminary characterization of this immune inhibitory activity. We have previously shown that E. coli lipopolysaccharide inhibited lysis ofE. coli without affecting the killing of B. subtilis (2, 8) . As assay methods we therefore used the inhibition of lysis ofE. coli D31 and the inhibition of killing of B. cereus Bcll. Table 3 shows that these assay methods gave different results for solubility in trichloroacetic acid and sensitivity to heat. The results imply that at least two inhibitory substances are present in the culture filtrate from strain Bt7. No effect was obtained with Trasylol, an inhibitor of proteolytic enzymes (cf. reference 13). The substance monitored by inhibition of strain D31 lysis will in the following be referred to as inhibitor A, whereas the substance assayed by blocking of strain Bcll killing will be called inhibitor B.
In an attempt to characterize these inhibitory assays, we compared the effects obtained by different amounts of culture filtrate. Figure  3 shows that for inhibitor A a sigmoid curve was obtained with a undiluted culture filtrate. After a threefold dilution, the inhibition was approximately proportional to the amount of culture filtrate added. This method can therefore be used as a quantitative assay for inhibitor A. Figure 4 shows that different amounts of culture filtrate to a varying degree inhibited the killing of strain Bcll. With undiluted culture filtrate, strain Bcll grew in the hemolymph. We previously used the killing ofE. coli as our main assay for the characterization of the im- 14, 1976 mune system in saturniid pupae (2, 3, 8) . This reaction is about 10:1 times more efficient than the killing of B. cereus shown in Fig. 4 . The assay of inhibitor B is therefore rather insensitive and at best a semiquantitative method for estimating this substance.
We next compared the amounts of inhibitor A produced by different strains during growth experiments. Figure 5 shows that the concentration of inhibitor A increased in the culture filtrate at the time when the bacteria were leaving the exponential phase of growth. Strains Bt7 and Bt72 produced about equal amounts of inhibitor A, whereas significantly lower levels were produced by strain Btll. In a similar experiment, we also compared the amounts of inhibitor A produced by a hemolysis-negative double mutant, its wild-type ancestor strain Btll, and the international reference strain INFECT. IMMUN.
E61. There were no significant differences among these three strains in the amounts of inhibitor A produced.
The results in Table 3 suggest that inhibitor A could be a macromolecule, whereas inhibitor B could be of a low-molecular-weight nature. We therefore subjected freeze-dried culture filtrate to a fractionation on a column with Sephadex G-25. The gel filtration in Fig. 6 shows that inhibitor A was eluted slightly after the void volume, whereas most of the material was retarded. Radioactive leucine was used as an intemal standard. Because of the time-consuming assay, we only tested certain of the fractions for the presence of inhibitor B. The result indicates that inhibitor B was also eluted with the void volume. The first peak was therefore pooled and precipitated with trichloroacetic acid to a final concentration of 5%. The precipi- Fi(;. 6. Gel filtration of freeze-dried culture filtrate from B. thuringiensis Bt7. The column (23 by 2 cm) contained Sephadex G-25, it was equilibrated with 0.1 M potassium phosphate buffer, pH 6.4, the flow rate was 60 ml/h, and the fraction volume was about 3 ml. Each fraction was assayed for ability to inhibit E. coli lysis (U), for adsorption in ultraviolet light (0), and for 14C (A) from the labeled leucine used as internal standard. (20) . Furthermore, we have shown that inhibitor A was produced by strains Bt7 and Bt72 (Fig. 5) , derivatives of serotype 3, which is known to be devoid of the ,B-exotoxin (G. Carlberg, thesis, Univ. of Helsinki, Helsinki, Finland, 1973) .
The y-endotoxin is both the main part of the protein crystal and a constituent of the spore coat (7, 18, 21) . Since the parental strains ofB. thuringiensis, Bt7 and Btll, are both crystal negative, our sporulation-deficient mutants, Bt72 and Bt12, should both be expected to pro-I 21
duce minimal amounts of the y-endotoxin. However, strains Btl2 and Bt72 both produced inhibitor A, and no difference was found in the amounts produced by the sporulation-negative mutant Bt72 and its parental strain Bt7 (Fig.  5) . It is therefore highly unlikely that inhibitor A could be identical to the y-endotoxin. Our hemolysis-negative double mutant is presumably deficient in the hemolytic factors described (14) . We therefore compared the amounts of inhibitor A produced by this hemolysis-negative strain and its wild-type ancestor. Since no difference was found, it is unlikely that inhibitor A is identical to any of the hemolysins.
We have also shown that an inhibitor of proteolytic enzymes (Trasylol) was without effect on inhibitors A and B. It is therefore unlikely that these substances are proteolytic enzymes (cf. reference 13) .
Can inhibitor B be identical to any of the known toxins? In our preliminary characterization inhibitor B was found to be heat stable and soluble in trichloroacetic acid. Therefore, it can hardly be of a protein nature and thus not identical to either the y-endotoxin, the hemolysins, or the metalloprotease. The ,-exotoxin is known to be heat stable and to inhibit in vitro synthesis of RNA and polyphenylalanine (1, 17, 22 ). Since we have previously shown that induction of immunity in Samia cynthia required both RNA and protein synthesis, we expected the 18-exotoxin to have an immunosuppressive effect on our insect system. However, our doseresponse curves (Fig. 1) showed that strains Gel filtration of culture filtrate from B. thuringiensis Bt7, extracted with 5% trichloroacetic acid. The column and the experimental conditions were the same as used in Fig. 6 . Each fraction was assayed for ability to inhibit the killing ofB. cereus Bcll (-) and for adsorption in ultraviolet light (0). Btll and Btl2, which both produce significant amounts of the 8-exotoxin, were much less virulent than Bt7 and its derivatives, which all are deficient in the f3-exotoxin. Furthermore, since sterile culture filtrate of the latter strains contain inhibitor B, this substance cannot be identical to the f-exotoxin.
Staphylococcal protein A and lipid A from gram-negative bacteria are both known to block the activity of mammalian complement (9, 24) . We have previously shown that the antibacterial activity in H. cecropia in several respects resembles complement and that lipid A in low concentrations is an effective inhibitor of the killing of E. coli (3, 8 Virulence of different strains of B. thuringiensis. Many investigators have previously tried to compare different strains of B. thuringiensis, in most cases by feeding spore-containing preparations to living insects and recording either the mean lethal dose or the food consumed (4, 5, 6, 21) . In our comparison of the virulence ofdifferent strains we always injected known doses of log-phase bacteria, and we recorded the number of viable cells in the hemolymph. This procedure eliminates the invasiveness of the bacteria as an experimental factor and makes it somewhat easier to discuss the remaining factors that contribute to the virulence. By this method of study, we have shown that in C. promethea there seems to be no significant contribution to the virulence from either the 1B-exotoxin or the -y-endotoxin. However, three other factors have been found that can contribute to the virulence, namely, the passive resistance toward the antibacterial activity and the production of the two inhibitors, A and B. Neither of these factors has been experimentally demonstrated before, and at the present stage we cannot safely estimate their respective contributions to the virulence.
It should be emphasized that the net result of an infection with injected B. thuringiensis must be a dynamic process in which bacterial synthesis ofthe immune inhibitors and the host synthesis of the immune proteins are competing with each other. In addition, the ability of the bacteria to repair the lesions caused by the defense reaction must be a factor of relevance. Since the interaction between the bacteria and the immune system, as well as between the inhibitor and the immune system, probably takes place with constant stoichiometric ratios, the ability of the different strains to produce the inhibitors, together with the growth rates, may become crucial factors that determine the final fate of an infection.
